Medicaments for the treatment of chronic obstructive pulmonary disease
1 Assignment
0 Petitions
Accused Products
Abstract
A pharmaceutical composition comprising a compound of formula 1
wherein:
- n is 1 or 2;
- R1 is hydrogen, C1–C4-alkyl, halogen, OH, or —O—C1–C4-alkyl;
- R2 is hydrogen, C1–C4-alkyl, halogen, OH, or —O—C1–C4-alkyl;
- R3 is hydrogen, C1–C4-alkyl, OH, halogen, —O—C1–C4-alkyl, —O—C1–C4-alkylene-COOH, or —O—C1–C4-alkylene-CO—O—C1–C4-alkyl, or
an acid addition salt thereof with a pharmacologically acceptable acid, or a solvate or hydrate thereof; and
a pharmaceutically acceptable excipient or carrier, and methods for using the pharmaceutical formulation in the treatment of chronic obstructive pulmonary disease (COPD).
45 Citations
20 Claims
- 1. A compound of formula 1
Specification